Augusta University
Patients with a high number of genes most associated with pathways that lead to cell death in lung cancer are at increased risk of dying early from their disease, researchers report.
For National Doctors' Day 2021, the Georgia Hospital Association spotlights Augusta University Health and its groundbreaking work during the COVID-19 pandemic.
Identifying more genetic mutations in an individual’s cancer enables more targeted treatment for patients. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those...
Fifteen hundred frontline workers are being recruited for a yearlong study to find what percentage are positive for the virus that causes COVID-19, what percentage become positive and whether the antibodies they produce protect them from reinfection.
Augusta University Health amps up the fight against COVID-19 with saliva testing.
As in-person classes resumed at Augusta University in early August, positive COVID-19 cases had hit a peak in the Augusta area and across Georgia, but those numbers are now on a “downhill slide,” according to Augusta University President Brooks A...
A rapid, cheap, and reliable pooling strategy for screening of SARS-CoV-2 maximizes available testing kits and resources in the COVID-19 pandemic.
Whether it is efforts to expand coronavirus screening and testing across the state by teaming up with Georgia National Guard and the Georgia Department of Public Health or becoming one of the first hospitals in the state to do convalescent plasma...
The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia Department of Pathology is now offering a new coronavirus test with expanded capacity to the entire state.
“We want patients and physicians in our community to have timely access to information that will ultimately benefit us all by helping limit spread of the virus,” says Dr. Ravindra Kolhe, director of the GEM Lab.
MCG scientists have found that high levels of a certain gene are correlated to better colorectal cancer survival rates. Next they hope to design a genetic panel that's predictive of prognosis - good or bad.
An MCG lab has been designated to help with patient testing for a trial assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say. High levels of this enzyme, indoleamine 2,3 dioxygenase, or IDO, at...
IBM’s Watson beat real-life contestants on Jeopardy. Now researchers are hoping this icon of artificial intelligence will help people with cancer win as well by providing a rapid, comprehensive report of the genetic mutations at the root of their...
Dr. Ravindra Kolhe was named to the American Society for Clinical Pathology’s 40 under 40 list.
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints. They have found in the synovial fluid of this joint, clear differences in the messages cells are...
A test that looks at the genetic expression of breast cancer cells to assess the 10-year recurrence risk and help physicians and patients make more selective treatment choices is now available at the Medical College of Georgia and the Georgia Cancer...
AUGUSTA, Ga. – Two existing chemotherapy drugs appear to be a powerful pair in targeting errant stem cells that are making breast cancer and enabling its spread and recurrence, scientists report. A combination of the drugs, 5-azacytidine and...
